the clinical outcome data in general populations is less mature than it is for tesamorelin (see Section 4)
Temprana SG, Mongiat LA, Yang SM, Trinchero MF, Alvarez DD, Kropff E, et al
In OASIS 4, common adverse reactions were similar to those previously seen in clinical trials with Wegovy (semaglutide) injection 2.4 mg, including nausea, diarrhoea and vomiting
However, the majority of EECs express several hormones that overlap between different enteroendocrine cells
Use proper technique: Rotate injection sites and follow guidelines to ensure comfort and effectiveness
The content on the SheMed blog is provided for general informational and educational purposes only